Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect.
Outcomes of COVID-19 Among Hospitalized Health Care Workers in North America.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect.
Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect. Acta Pharmacol Sin. 2004 Jul; 25(7):927-31.
View in:
PubMed
subject areas
Animals
Anti-Inflammatory Agents, Non-Steroidal
Arthritis, Experimental
Cyclooxygenase 1
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Edema
Humans
Isoenzymes
Male
Membrane Proteins
Mice
Mice, Inbred C57BL
Prostaglandin-Endoperoxide Synthases
Pyrroles
Rats
Rats, Wistar
RNA, Messenger
Sulfides
U937 Cells
authors with profiles
Aiping Bai